Recombinant Human PTGIR Protein，His

PTGIR, or Prostaglandin I2 Receptor, is a critical G-protein coupled receptor (GPCR) that plays a significant role in various physiological processes, including vasodilation, inhibition of platelet aggregation, and modulation of inflammation. Understanding the structure and function of PTGIR is crucial for developing targeted therapies for cardiovascular diseases and other conditions associated with dysregulated prostaglandin signaling. The research surrounding PTGIR has intensified in recent years, particularly with the growing interest in GPCRs as therapeutic targets due to their involvement in numerous cellular responses. Recombinant PTGIR proteins have been expressed and purified to facilitate detailed biochemical and biophysical studies, allowing researchers to elucidate the receptor's signaling mechanisms and interactions with ligands, including its natural agonists, such as prostacyclin. These studies also seek to uncover the nuances of PTGIR's role in pathophysiological states, including atherosclerosis and hypertension, providing insights into potential drug development strategies. Additionally, advancements in molecular biology techniques have enabled the exploration of PTGIR's structure-function relationships, paving the way for innovative pharmacological interventions. Ultimately, the ongoing research on PTGIR recombinant proteins holds promise for improving our understanding of cardiovascular health and disease, offering avenues for novel therapeutic approaches.